Izotropic Corporation
Izotropic Corporation, a research and development company, develops diagnostic products for detecting breast cancers. The company develops and commercializes IzoView, a CT diagnostic imaging device with a platform of targeted uses offering high resolution, true 3D dedicated breast imaging with 360-degree image acquisition and can be used with or without injectable contrast. Izotropic Corporation … Read more
Izotropic Corporation (IZOZF) - Total Liabilities
Latest total liabilities as of October 2025: $5.95 Million USD
Based on the latest financial reports, Izotropic Corporation (IZOZF) has total liabilities worth $5.95 Million USD as of October 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Izotropic Corporation - Total Liabilities Trend (2017–2025)
This chart illustrates how Izotropic Corporation's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Izotropic Corporation Competitors by Total Liabilities
The table below lists competitors of Izotropic Corporation ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Isofol Medical AB
ST:ISOFOL
|
Sweden | Skr21.52 Million |
|
Earth Tech Environment Public Company Limited
BK:ETC
|
Thailand | ฿841.10 Million |
|
LGMS Berhad
KLSE:0249
|
Malaysia | RM12.51 Million |
|
Opter AB
ST:OPTER
|
Sweden | Skr13.27 Million |
|
Bayview Acquisition Corp Unit
NASDAQ:BAYAU
|
USA | $5.11 Million |
|
Ozsu Balik Uretim A.S.
IS:OZSUB
|
Turkey | TL2.01 Billion |
|
3P Learning Ltd
AU:3PL
|
Australia | AU$58.50 Million |
|
Principal Technologies Inc
V:PTEC
|
Canada | CA$1.57 Million |
Liability Composition Analysis (2017–2025)
This chart breaks down Izotropic Corporation's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.07 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -1.08 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 13.30 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Izotropic Corporation's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Izotropic Corporation (2017–2025)
The table below shows the annual total liabilities of Izotropic Corporation from 2017 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-04-30 | $5.27 Million | +29.30% |
| 2024-04-30 | $4.08 Million | +16.01% |
| 2023-04-30 | $3.52 Million | +32.99% |
| 2022-04-30 | $2.64 Million | +1461.67% |
| 2021-04-30 | $169.28K | +141.86% |
| 2020-04-30 | $69.99K | +215.07% |
| 2019-04-30 | $22.21K | -73.51% |
| 2018-04-30 | $83.87K | -60.87% |
| 2017-04-30 | $214.36K | -- |